South African researchers hope to restart the use of Johnson & Johnson’s COVID-19 vaccine next week in an “implementation study” immunising healthcare workers, a top local scientist said on Wednesday.
South Africa suspended the study last week after US federal health agencies recommended pausing the use of J&J’s vaccine because of rare cases of blood clots.
“We do hope to start again next week,” South African Medical Research Council President Glenda Gray said during a webinar.
![[File Image]: A nurse at one of South Africa's hospital during the height of the coronavirus pandemic.](https://www.sabcnews.com/sabcnews/wp-content/uploads/2021/01/HOSPITAL.jpg)
